BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31642163)

  • 1. A Nanoscale Metal-Organic Framework to Mediate Photodynamic Therapy and Deliver CpG Oligodeoxynucleotides to Enhance Antigen Presentation and Cancer Immunotherapy.
    Ni K; Luo T; Lan G; Culbert A; Song Y; Wu T; Jiang X; Lin W
    Angew Chem Int Ed Engl; 2020 Jan; 59(3):1108-1112. PubMed ID: 31642163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
    Ni K; Luo T; Nash GT; Lin W
    Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoscale Metal-Organic Framework Overcomes Hypoxia for Photodynamic Therapy Primed Cancer Immunotherapy.
    Lan G; Ni K; Xu Z; Veroneau SS; Song Y; Lin W
    J Am Chem Soc; 2018 May; 140(17):5670-5673. PubMed ID: 29665677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. π-Extended Benzoporphyrin-Based Metal-Organic Framework for Inhibition of Tumor Metastasis.
    Zeng JY; Zou MZ; Zhang M; Wang XS; Zeng X; Cong H; Zhang XZ
    ACS Nano; 2018 May; 12(5):4630-4640. PubMed ID: 29584395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic Therapy Combined with Antihypoxic Signaling and CpG Adjuvant as an In Situ Tumor Vaccine Based on Metal-Organic Framework Nanoparticles to Boost Cancer Immunotherapy.
    Cai Z; Xin F; Wei Z; Wu M; Lin X; Du X; Chen G; Zhang D; Zhang Z; Liu X; Yao C
    Adv Healthc Mater; 2020 Jan; 9(1):e1900996. PubMed ID: 31746153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorin-Based Nanoscale Metal-Organic Framework Systemically Rejects Colorectal Cancers via Synergistic Photodynamic Therapy and Checkpoint Blockade Immunotherapy.
    Lu K; He C; Guo N; Chan C; Ni K; Weichselbaum RR; Lin W
    J Am Chem Soc; 2016 Sep; 138(38):12502-10. PubMed ID: 27575718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Titanium-Based Nanoscale Metal-Organic Framework for Type I Photodynamic Therapy.
    Lan G; Ni K; Veroneau SS; Feng X; Nash GT; Luo T; Xu Z; Lin W
    J Am Chem Soc; 2019 Mar; 141(10):4204-4208. PubMed ID: 30779556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoscale Metal-Organic Framework Mediates Radical Therapy to Enhance Cancer Immunotherapy.
    Ni K; Aung T; Li S; Fatuzzo N; Liang X; Lin W
    Chem; 2019 Jul; 5(7):1892-1913. PubMed ID: 31384694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.
    Kim S; Kim SA; Nam GH; Hong Y; Kim GB; Choi Y; Lee S; Cho Y; Kwon M; Jeong C; Kim S; Kim IS
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma.
    Xu J; Zheng Q; Cheng X; Hu S; Zhang C; Zhou X; Sun P; Wang W; Su Z; Zou T; Song Z; Xia Y; Yi X; Gao Y
    J Nanobiotechnology; 2021 Oct; 19(1):355. PubMed ID: 34717654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metal-Organic Frameworks with Enhanced Photodynamic Therapy: Synthesis, Erythrocyte Membrane Camouflage, and Aptamer-Targeted Aggregation.
    Zhao Y; Wang J; Cai X; Ding P; Lv H; Pei R
    ACS Appl Mater Interfaces; 2020 May; 12(21):23697-23706. PubMed ID: 32362109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoscale metal-organic frameworks for x-ray activated in situ cancer vaccination.
    Ni K; Lan G; Guo N; Culbert A; Luo T; Wu T; Weichselbaum RR; Lin W
    Sci Adv; 2020 Oct; 6(40):. PubMed ID: 33008911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum: A Nanoscale Metal-Organic Framework to Mediate Photodynamic Therapy and Deliver CpG Oligodeoxynucleotides to Enhance Antigen Presentation and Cancer Immunotherapy.
    Ni K; Luo T; Lan G; Culbert A; Song Y; Wu T; Jiang X; Lin W
    Angew Chem Int Ed Engl; 2022 Oct; 61(41):e202211958. PubMed ID: 36177826
    [No Abstract]   [Full Text] [Related]  

  • 14. Near-Infrared-Triggered Photodynamic Therapy with Multitasking Upconversion Nanoparticles in Combination with Checkpoint Blockade for Immunotherapy of Colorectal Cancer.
    Xu J; Xu L; Wang C; Yang R; Zhuang Q; Han X; Dong Z; Zhu W; Peng R; Liu Z
    ACS Nano; 2017 May; 11(5):4463-4474. PubMed ID: 28362496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-Triggered Nanoscale Metal-Organic Frameworks for Enhanced Anticancer Activity.
    Liu M; Wang L; Zheng X; Liu S; Xie Z
    ACS Appl Mater Interfaces; 2018 Jul; 10(29):24638-24647. PubMed ID: 29957930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoscale Metal-Organic Frameworks Stabilize Bacteriochlorins for Type I and Type II Photodynamic Therapy.
    Luo T; Ni K; Culbert A; Lan G; Li Z; Jiang X; Kaufmann M; Lin W
    J Am Chem Soc; 2020 Apr; 142(16):7334-7339. PubMed ID: 32248686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose X-ray radiotherapy-radiodynamic therapy via nanoscale metal-organic frameworks enhances checkpoint blockade immunotherapy.
    Lu K; He C; Guo N; Chan C; Ni K; Lan G; Tang H; Pelizzari C; Fu YX; Spiotto MT; Weichselbaum RR; Lin W
    Nat Biomed Eng; 2018 Aug; 2(8):600-610. PubMed ID: 31015630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple and powerful co-delivery system based on pH-responsive metal-organic frameworks for enhanced cancer immunotherapy.
    Duan F; Feng X; Yang X; Sun W; Jin Y; Liu H; Ge K; Li Z; Zhang J
    Biomaterials; 2017 Apr; 122():23-33. PubMed ID: 28107662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering of Upconverted Metal-Organic Frameworks for Near-Infrared Light-Triggered Combinational Photodynamic/Chemo-/Immunotherapy against Hypoxic Tumors.
    Shao Y; Liu B; Di Z; Zhang G; Sun LD; Li L; Yan CH
    J Am Chem Soc; 2020 Feb; 142(8):3939-3946. PubMed ID: 31968933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in nanoscale metal-organic frameworks for drug release and cancer therapy.
    He L; Liu Y; Lau J; Fan W; Li Q; Zhang C; Huang P; Chen X
    Nanomedicine (Lond); 2019 May; 14(10):1343-1365. PubMed ID: 31084393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.